ReviewMaterials today. Bio2025
Biofouling-resistant nanomaterials for non-enzymatic glucose sensors: A critical review.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond Sensitivity: A Perspective on Transitioning Photonic Sensors into Real-Life Applications.Sensors (Basel, Switzerland) · 2026Review
- A Review on Catalytic Nanostructured Electrodes for Wearable and Implantable Abiotic Glucose Fuel Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Clinical biomarkers and biosensors for early detection of metabolic dysfunction-associated steatohepatitis (MASH): a translational perspective.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biofouling is a significant concern in sensors and diagnostic applications as it results in reduced sensitivity, selectivity, and response time, false signals or noise, and ultimately causes a reduction in the sensor lifespan. This is particularly a concern while developing non-enzymatic glucose sensors (NEGS) that can be used to fabricate implantable sensors for continuous glucose monitoring. Thus, developing advanced materials solutions in the form of nanomaterials that display inherent antifouling activity is imperative. Due to their small nanosized dimensions and tunable microstructures, nanomaterials display unique physio-chemical properties that display antifouling efficiency and thus can be applied towards developing highly stable, sensitive, and selective NEGS. Through this review, we aim to explore the recent advances in the field of antifouling nanomaterials that offer promising potential to be applied towards developing NEGS. We discuss the details of various biofouling-resistant nanomaterials, including graphene and graphene oxide, carbon nanotubes, gold nanoparticles, silver nanoparticles, metal oxide nanoparticles, and polymeric nanocomposites. Further, we highlighted the possible mechanism of action involving nanomaterials in providing antifouling features in NEGS, followed by a brief discussion of the advantages and disadvantages of using nanomaterials for antifouling in developing NEGS. Finally, we concluded the article by proposing the future prospects of this promising technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.